期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 63, 期 5, 页码 2240-2262出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.9b00898
关键词
-
资金
- EPSRC [EP/R00188X/1]
- Alfonso Martin Escudero Foundation
- Imperial College London [105603/Z/14/Z]
- Wellcome Trust [105603/Z/14/Z]
- EPSRC Doctoral Training Partnership award [EP/R512540/1]
- Medicines for Malaria Venture [RD/08/2800]
- Wellcome [100993/Z/13/Z]
- Wellcome Trust [105603/Z/14/Z] Funding Source: Wellcome Trust
- EPSRC [EP/R00188X/1, 2033046] Funding Source: UKRI
Malaria is still a leading cause of mortality among children in the developing world, and despite the immense progress made in reducing the global burden, further efforts are needed if eradication is to be achieved. In this context, targeting transmission is widely recognized as a necessary intervention toward that goal. After carrying out a screen to discover new transmission-blocking agents, herein we report our medicinal chemistry efforts to study the potential of the most robust hit, DDD01035881, as a male-gamete targeted compound. We reveal key structural features for the activity of this series and identify analogues with greater potency and improved metabolic stability. We believe this study lays the groundwork for further development of this series as a transmission blocking agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据